Genetics and Phantom Limb Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-03

Study Completion Date

2014-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

\- Many people who lose a limb feel pain in the missing limb. This feeling is called phantom limb pain. Researchers do not fully understand what causes this pain. Differences in people's genes may play a role. Comparing the genes of people with and without phantom limb pain may help researchers better understand this feeling, who is likely to develop it, and how to treat it.

Objectives:

\- To study whether genetic differences affect phantom limb pain.

Eligibility:

\- Individuals at least 18 years of age who have lost an arm or leg at least 3 months ago.

Design:

* Participants will be screened with a medical history and physical exam.
* Participants will answer questions about how they lost the limb, and whether they feel phantom limb pain. They will also have a test to measure their sensitivity to heat and cold.
* Participants will provide a blood sample for genetic testing.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Identify the Genetic Variations Associated With Phantom Limb Pain

NCT01462448

Phantom Limb

COMPLETED

Pain Predict Genetics

NCT02383342

Chronic Pain Acute Pain

RECRUITING

Exploring the Genetics of Neuropathic Pain

NCT03862365

Neuropathic Pain Genetic Predisposition Polyneuropathies

RECRUITING

Alzheimer's Disease Genetics Study

NCT00064870

Alzheimer Disease Late Onset Alzheimer Disease Dementia

RECRUITING

Blood Sample Donations to Study the Role of Genes in Pain

NCT00341367

Pain

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objectives:

The proposed clinical trial will investigate the role of the human genome including genetic variations and gene expression profiles on the development of phantom limb pain (PLP).

Study population:

Patients will be recruited from military personnel with major limb amputations. A total of one thousand subjects with upper or lower extremity amputations of any level will be enrolled in this study.

Design:

Eight hundred subjects with chronic PLP (PLP patient) and 200 patients without PLP (non-PLP patient) will assess the severity of their pain symptom. Each participant will undergo a routine blood draw from which DNA and RNA will be harvested.

Outcome measures:

Using Affymetrix SNP 6.0 technology, which identifies up to 1 million single nucleotide polymorphisms (SNPs) and 1 million copy number variations in the human genome, the differences in genomic variations between the PLP and the non-PLP patients will be analyzed. An extreme subset of PLP patients will be tested for their quantitative sensory function and profiled gene expression and epigenetic pattern with the Affymetrix Human Exon ST 1.0 and Illumina Genome Analyzer IIx. These integrative genomic analyses using genetic variations, gene expression and epigenetic profile could explain why some amputees experience chronic PLP and some do not. By studying these responses in patient samples, we will evaluate the role of genomic factors in PLP. SNP frequencies, gene expression and epigenetic profiles between PLP and non-PLP groups will be analyzed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polymorphism-Genetic Amputation Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

PLP GROUP:

* at least 18 years of age
* Single or multiple upper and/or lower limb amputation
* At least three months post-amputation
* Ability to follow study instructions in English
* Currently present on-going PLP for at least one month and at least 3 times per week

NON PLP GROUP:

-same with PLP group except:

--Experienced PLP less than 10 times total and/or for less than two weeks

Exclusion Criteria

BOTH PLP AND NON-PLP GROUPS:

* Chronic systemic disease which might affect pain sensitivity and ability to participate in this study s blood draw
* Any disease (such as hemophilia) or medication regimen (such as warfarin) increasing hemorrhage that would make a blood draw dangerous or inadvisable for the subject
* Known uncontrolled systemic diseases; known cancer not in remission, known on-going infection, lupus, kidney disease requiring dialysis, any other systemic disease which might affect ability to participate in this study s blood draw
* Inability to provide his/her own informed consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No